Swiss expansion for Ferring
Ferring Pharmaceuticals has unveiled plans to invest €90 million in a state-of-the-art production site in Saint-Prex in Switzerland.
Archives for September 14, 2003
Maiden results and new deals for BioProgress
Capsule technology company BioProgress has reported its first set of interim results since becoming an AIM-listed company, as well as a distribution deal with Hoefliger.
Australian pharma woes continue
Australian Pharmaceutical Industries follows Pan Pharma as license to make products is revoked; government is planning crackdown on the drug industry